top of page

STANDING STATEMENTS

Legal and regulatory

Investigational status

VRX-001 is an investigational medicinal product. It is not authorised by the Medicines and Healthcare products Regulatory Agency, the European Medicines Agency, the United States Food and Drug Administration, or any other regulator, in any territory. No claim is made anywhere on this website about its safety or its efficacy.

Not an offer of securities

Nothing on this website is an offer of, or an invitation to subscribe for or acquire, securities in Varex Bioscience Limited, nor an inducement to engage in investment activity. Nothing here is investment, legal or tax advice. Any investor material is provided separately and directly, and only to persons to whom it may lawfully be provided.

Medical information

Information about 22q11.2 deletion syndrome on this website is provided for general information, is referenced to published clinical guidelines, and is not medical advice. It is not a substitute for the judgement of a qualified clinician. Varex Bio cannot respond to requests for advice on personal medical matters.

Industry codes

Varex Bio is not a member of the Association of the British Pharmaceutical Industry and has not accepted the jurisdiction of the Prescription Medicines Code of Practice Authority. This website has been prepared having regard to the ABPI Code of Practice and to the MHRA Blue Guide on the advertising and promotion of medicines.

Territory

This website is directed at readers in the United Kingdom. It is not directed at persons in the United States, and nothing on it is intended for a United States audience. Rules on what may be said about medicines under development differ between territories.

Forward-looking statements

Statements about intentions, plans, timing or expectations are forward-looking. They reflect the position at the date stated and are subject to change. Drug development is uncertain and most programmes do not reach approval.

Company information

Registered name

Varex Bioscience Limited

Company number

17220992

Place of registration

England and Wales

Registered office

89 Gawsworth Road, Macclesfield, England, SK11 8UQ

Reviewed August 2026.

Varex Bioscience Limited (Varex Bio). Registered in England and Wales, company number 17220992. Registered office: 89 Gawsworth Road, Macclesfield, England, SK11 8UQ.

​​

​VRX-001 is an investigational medicinal product. It is not authorised in any territory and is not available for supply. Varex Bio does not supply it, or any product containing it, to any person.

​​​

Nothing on this website is an offer of securities, an invitation to invest, or investment, legal, tax or medical advice. This website is directed at readers in the United Kingdom and is not directed at US persons. Statements about future plans are subject to change.

​

Varex Bio is not a member of the Association of the British Pharmaceutical Industry and has not accepted the jurisdiction of the Prescription Medicines Code of Practice Authority. This website has been prepared having regard to the ABPI Code of Practice and the MHRA Blue Guide.

bottom of page